BHBausch Health BHC · NYSE
$6.47 +0.23% (+$0.02)
- Market cap
- $2.41B
- Enterprise value
- $21.4B
- P/E
- -
- Forward P/E
- 1.4x
- PEG
- -
- P/S
- 0.2x
- P/FCF
- 1.7x
- EV/EBITDA
- 10.4x
- ROIC
- 19.5%
- Bruto marža
- 71.8%
- Neto marža
- -10.1%
- Dividend yield
- -
- Payout ratio
- -
- Neto dolg/EBITDA
- 9.3x
- Beta
- 0.37
- Free float
- 88.6%
O podjetju
Bausch Health Companies Inc. is a Canadian pharmaceutical company focused on the development and manufacturing of medicines and healthcare products. Originally founded in 1959 as Valeant Pharmaceuticals, the company rebranded as Bausch Health in 2018, shifting its focus to products in ophthalmology, dermatology, dental care, and cardiovascular medicine. Bausch Health specializes in prescription drugs, over-the-counter products, and innovative medical devices, and is known for its strong portfolio in ophthalmology and medical technologies.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Thomas J. Appio
Employees
20,300
Headquarters
Laval
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke